Skip to main content
. 2020 Oct 14;10:560025. doi: 10.3389/fonc.2020.560025

Figure 10.

Figure 10

Validation of the prognostic value of serum exosomal miR-125b-5p in NSCLC. (A) Relative expression of miR-125b-5p in NSCLC compared to normal tissue in TCGA database. (B) Kaplan-Meier survival analysis of TGCA patients with low-expression and high-expression miR-125b-5p groups. TN, normal tissue; TT, tumor tissue. (**P < 0.01).